Feature Channels

Meeting News

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Keywords:

Novel Rose Bengal Formulation Obliterates Lesions in Patients with Deadliest of Melanomas

A formulation of the dye, rose bengal, which has been around for more than a century, has recently been shown to have promise in patients with cutaneous melanoma, one of the deadliest forms of the disease.

View | Comment

Medicine

Channels:

Keywords:

Study: Widespread Vitamin D Deficiency in Thyroidectomy Patients

A new study from researchers at Henry Ford Hospital in Detroit finds widespread vitamin D deficiency among patients who undergo a thyroidectomy, potentially putting them at greater risk for developing dangerously low blood calcium levels after surgery.

View | Comment

Medicine

Channels:

Keywords:

Study: Pain Keeps Surgery Patients Awake, Extends Hospital Stay

Pain can make it difficult for some patients to get a good night’s rest while recovering in the hospital following certain surgical procedures, often resulting in longer hospital stays, according to researchers at Henry Ford Hospital in Detroit.

View | Comment

Medicine

Channels:

Keywords:

Clifford Hudis, M.D., to Anchor Mayo Clinic Genomics Conference

Mayo Clinic announced today that Clifford Hudis, M.D., immediate past president of the American Society of Clinical Oncology (ASCO), will deliver the keynote address at Individualizing Medicine 2014: From Promise to Practice.

View | Comment

Medicine

Channels:

Keywords:

MS Drug Candidate Shows New Promise

Positive new data have been released on a drug candidate, RPC1063, for relapsing multiple sclerosis that was first discovered and synthesized at The Scripps Research Institute (TSRI).

View | Comment

Medicine

Channels:

Keywords:

New Targeted Radiosurgery Technology Provides Highly Accurate Treatment, Greater Patient Comfort

623327-image4.jpg

A new stereotactic radiosurgery system provides the same or a higher level of accuracy in targeting cancer tumors – but offers greater comfort to patients and the ability to treat multiple tumors at once – when compared to other radiation therapy stereotactic systems, according to researchers at Henry Ford Hospital in Detroit. Research results will be presented at ASTRO's 56th Annual Meeting.

View | Comment

Medicine

Channels:

Keywords:

Analysis Finds Select Group of Stage IV Lung Cancer Patient Population Achieves Long-Term Survival After Aggressive Treatments

A large, international analysis of patients with stage IV non-small cell lung cancer (NSCLC) indicates that a patient’s overall survival (OS) rate can be related to factors including the timing of when metastases develop and lymph node involvement, and that aggressive treatment for “low-risk” patients leads to a five-year OS rate of 47.8 percent, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting.

View | Comment

Medicine

Channels:

Keywords:

Patients with Non-Small Cell Lung Cancer (NSCLC) Who Have Never Smoked or Who Have Quit Smoking Have Lower Risk of Developing Secondary Primary Lung Cancers Than Current Smokers

Non-small cell lung cancer (NSCLC) survivors who never smoked or who are former smokers at the time of diagnosis have a lower risk of developing secondary primary lung cancers (SPLC) compared to those who are current smokers, suggesting that increased tobacco exposure is associated with a higher risk of SPLC, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting.

View | Comment

Medicine

Channels:

Keywords:

Long-Term Results of RTOG 0236 Confirm Good Primary Tumor Control and Positive Five-Year Survival Rates for Lung Cancer Patients Who Received Stereotactic Body Radiation Therapy

Patients with inoperable, early-stage lung cancer who receive stereotactic body radiation therapy (SBRT) have a five-year survival rate of 40 percent, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting.

View | Comment

Medicine

Channels:

Keywords:

Patient Reported Data Indicates That Single Fraction Radiation Therapy Is as Effective as Multiple Fraction Radiation Therapy for Patients with Bone Metastases in a Broad Clinical Setting

A prospective study that compared patient-reported outcomes of a broad set of cancer patients with bone metastases demonstrates that single fraction radiation therapy (SFRT) is equally as effective as multiple fraction radiation therapy (MFRT) when pain, function and quality of life are considered, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting.

View | Comment